Enlivex Therapeutics (ENLV) announced that the Company completed enrollment of all patients in the Phase II stage of its randomized, ...

Therapeutics announces that its ongoing Phase 3 clinical study has consented over 100 and has enrolled over 75 patients.

Enlivex Therapeutics Ltd. has announced the completion of patient enrollment in the Phase II stage of its clinical trial for Allocetra™, an immunotherapy for moderate to severe knee ...